What does CUSIP 015117B10 represent in this 13F holders report?

CUSIP 015117B10 is the security identifier for 015117B10 - CELLDEX THERAPEUTICS INC NEW - COM used to aggregate holder disclosures.

How many institutions held 015117B10 - CELLDEX THERAPEUTICS INC NEW - COM in Q2 2014?

No institutional holders were reported for 015117B10 - CELLDEX THERAPEUTICS INC NEW - COM in Q2 2014; review adjacent reporting periods for trend context.

CELLDEX THERAPEUTICS INC NEW - COM

CUSIP: 015117B10

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class: Equity / COM
Total 13F shares: 0
Share change: -119,364
Total reported value: $0
Number of holders: 0
Value change: -$2,109
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 015117B10?
CUSIP 015117B10 identifies 015117B10 - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2015
Previous quarter: Q1 2014

Recent filing periods for CUSIP 015117B10:

Q4 2016 Q3 2016 Q3 2015 Q2 2015 Q2 2014 Q1 2014 Q4 2013

CELLDEX THERAPEUTICS INC NEW - COM

Q2 2014 13F Holders as of 30 Jun 2014

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of CELLDEX THERAPEUTICS INC NEW - COM as of Q2 2014.